A Phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed diffuse large B cell lymphoma Grade IIIb Follicular Lymphoma transformed lymphoma and high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements
Brief description of study
A Phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed diffuse large B cell lymphoma, Grade IIIb Follicular Lymphoma, transformed lymphoma, and high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements
Clinical Study Identifier: s21-01259
ClinicalTrials.gov Identifier: NCT04799275
Principal Investigator:
Catherine M Diefenbach.
Other Investigators:
Maxim Kreditor,
Marc Justin Braunstein,
Elizabeth A Raetz,
Jaime Andres Suarez Londono,
Vathveal Mathews,
Bruce G Raphael,
Kenneth B Hymes,
Jingmei Hsu,
Elizabeth Ann Roman,
Ellaine R Yap,
Michael L. Grossbard,
John Leslie Vaughn,
Shella Saint Fleur-Lominy,
David Kaminetzky,
Kathryn Dowling,
Michael E Garrison,
Tibor Moskovits,
Bonnie Kiner-Strachan,
Thaleshravi Prashad.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.